Meritage Accountable Care Organization (ACO)

ACO Name and Location

Meritage ACO, LLC
4 Hamilton Lndg
Ste 100
Novato, California 94949

ACO Primary Contact

Primary Contact NameMarcy Norenius
Primary Contact Phone Number415-884-1825
Primary Contact Email Addressmnorenius@meritagemed.com

Organizational Information

ACO participants:

ACO ParticipantsACO Participant in Joint Venture (Enter Y or N)
Ronald J Botelho LtdY
Kathryn Najafi-Tagol, M.D.Y
Marin GastroenterologyY
Soluna Health, Inc.Y
Curtis F. Robinson, M.D., IncY
Holly C. Kelly, M.D., Inc.Y
John D. Hollander, D.P.M., inc.Y
Santa Rosa Sports Medicine, Inc.Y
Darya Soto, MD Inc.Y
Daniel J. Solomon, Md IncY
Prima Medical FoundationY
Sonoma Family PracticeY
Marin NephrologyY
Marin Cancer Care, Inc.Y
Andrew SawickiY
Rachel Hoyal Dpm Inc A Professional CorporationY
John AndrewY
Richard E. PowersY
Nancy Davidson, MDY
First Med Marin Medical ClinicY
Andrew Sawicki, D.P.M.Y
Francis T. Healy, M.D., F.C.C.P., A Prof CorpY
Bart Gershbein, M.D.Y
Shan Kaur, M.D.Y
Thomas Fitzgerald, DPMY
Mt. Tam Orthopedics, A Medical Center, Inc.Y
Brad Drexler, M.D.Y
Napa Valley Family Medical Group, IncY
Anesthesiology Cnslts of Marin A Med Grp InY
Sonoma Valley Community Health CenterY
Dr. James Bryan Robison D.P.M.Y
Noah D. Weiss, M.D., IncY
J. Timothy Murphy, M.D.Y
Dominic Paul Amara, M.D.Y
Marin Hospitalist Medical Group, Inc.Y
Winthrop H. Hall, Jr., M.D.Y
Lizellen LaFollette, M.D.Y
Robert Harf Orthopaedics A Professional CorporationY
Neurology Clinic of Marin, A Medical CorporationY
John AndrewY
John J. Jolley, M.D.A Professional CorporationY
No. CA Minimally-Invasive Cardiovascular Surgery Inc.Y
Ross Valley Medical Corp.N
Nephrology AssociatesY
Marin Healthcare DistrictY
Marin Medical LaboratoriesY
J. Nevin Smith, M.D.Y
Santa Rosa Orthopaedic Medical Group IncY
Clinton Lane, M.D.Y
San Francisco Foot and Ankle CenterY
Robert D Teasdale JrY
Marin Ophthalmic Consultants, A Medical CorporationY
Marin General HospitalY
Hospice by the BayY
Eitan Homa Jennifer KrasnoffY

 

ACO governing body:

Last Name
First Name
Position
Members Voting Power
Membership Type
Licensed Business Name
Chamberlin
Keith
Board Chair/President
1 vote
Member
Anesthesia Consultants of Marin
Habis
Joseph
Medical Director
1 vote
Member
Prima Medical Group
Johnson
Ed
Board Member
1 vote
Medicare Beneficiary Representative
n/a
Wexman
Mark
Treasurer
1 vote
Member
Cardiovascular Associates of Marin
Sklar
Joel
Board Member
1 vote
Member
Marin General Hospital
Bickhoff
Harvey
Board Member
1 vote
Member
Marin Cancer Care
Sowerby
Timothy
Board Member
1 vote
Member
Marin Gastroenterology


Key ACO clinical and administrative leadership:

Mark WexmanACO Executive
Joseph HabisMedical Director
Kim NoonCompliance Officer
Jess BobierQuality Assurance/Improvement Officer

Associated committees and committee leadership:

Committee NameCommittee Leader Name and Position
Quality Improvement CommitteeJoseph Habis, MD (Medical Director)

Types of ACO participants, or combinations of participants, that formed the ACO:

  • Networks of individual practices of ACO professionals

Shared Savings and Losses

Amount of Shared Savings/Losses

  • Second Agreement Period
    • Performance Year 2016, $0
  • First Agreement Period
    • Performance Year 2015, $0
    • Performance Year 2014, $0
    • Performance Year 2013, $0

Shared Savings Distribution

  • Second Agreement Period
    • Performance Year 2016
      • Proportion invested in infrastructure: N/A
      • Proportion invested in redesigned care processes/resources: N/A
      • Proportion of distribution to ACO participants: N/A
  • First Agreement Period
    • Performance Year 2015
      • Proportion invested in infrastructure: N/A
      • Proportion invested in redesigned care processes/resources: N/A
      • Proportion of distribution to ACO participants: N/A
    • Performance Year 2014
      • Proportion invested in infrastructure: N/A
      • Proportion invested in redesigned care processes/resources: N/A
      • Proportion of distribution to ACO participants: N/A
    • Performance Year 2013
      • Proportion invested in infrastructure: N/A
      • Proportion invested in redesigned care processes/resources: N/A
      • Proportion of distribution to ACO participants: N/A

Quality Performance Results

2016 Quality Performance Results:

ACO#Measure NameRateACO Mean
ACO-1CAHPS: Getting Timely Care, Appointments, and Information82.7080.51
ACO-2CAHPS: How Well Your Providers Communicate92.8693.01
ACO-3CAHPS: Patients’ Rating of Provider91.9092.25
ACO-4CAHPS: Access to Specialists82.2483.49
ACO-5CAHPS: Health Promotion and Education61.6460.32
ACO-6CAHPS: Shared Decision Making75.3175.40
ACO-7CAHPS: Health Status/Functional Status76.1472.30
ACO-34CAHPS: Stewardship of Patient Resources23.0926.97
ACO-8Risk Standardized, All Condition Readmission14.4914.70
ACO-35Skilled Nursing Facility 30-day All-Cause Readmission measure (SNFRM)18.2618.17
ACO-36All-Cause Unplanned Admissions for Patients with Diabetes40.2453.20
ACO-37All-Cause Unplanned Admissions for Patients with Heart Failure60.9775.23
ACO-38All-Cause Unplanned Admissions for Patients with Multiple Chronic Conditions49.4859.81
ACO-9Ambulatory Sensitive Condition Admissions: Chronic Obstructive Pulmonary Disease or Asthma in Older Adults (AHRQ Prevention Quality Indicator (PQI) #5)5.699.27
ACO-10Ambulatory Sensitive Conditions Admissions: Heart Failure (AHRQ Prevention Quality Indicator (PQI) #8)14.0314.53
ACO-11Percent of PCPs who Successfully Meet Meaningful Use Requirements76.2782.72
ACO-39Documentation of Current Medications in the Medical Record79.5887.54
ACO-13Falls: Screening for Future Fall Risk45.6064.04
ACO-14Preventive Care and Screening: Influenza Immunization63.4868.32
ACO-15Pneumonia Vaccination Status for Older Adults71.1969.21
ACO-16Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up62.6374.45
ACO-17Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention93.8190.98
ACO-18Preventive Care and Screening: Screening for Clinical Depression and Follow-up Plan40.4353.63
ACO-19Colorectal Cancer Screening65.4061.52
ACO-20Breast Cancer Screening81.3167.61
ACO-21Preventive Care and Screening: Screening for High Blood Pressure and Follow-Up Documented44.7676.79
ACO-42Statin therapy for the Prevention and Treatment of Cardiovascular Disease70.8177.72
ACO-27Diabetes Mellitus: Hemoglobin A1c Poor Control12.5418.24
ACO-41Diabetes: Eye Exam39.4344.94
ACO-28Hypertension (HTN): Controlling High Blood Pressure65.9370.69
ACO-30Ischemic Vascular Disease (IVD): Use of Aspirin or Another Antithrombotic74.0685.05
ACO-31Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD)93.4888.67
ACO-33Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy – for patients with CAD and Diabetes or Left Ventricular Systolic Dysfunction (LVEF<40%)71.3379.67

Please note, the ACO-40 Depression Remission at 12 months quality measure is not included in public reporting due to low samples.

Note: In the Quality Performance Results file(s) above, search for “Meritage ACO, LLC” to view the quality performance results. This ACO can also be found by using the ACO ID A82661 in the public use files on data.cms.gov.

Payment Rule Waivers

  • No, our ACO does not use the SNF 3-Day Rule Waiver.